Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy

Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy

Congli Jia,1 Zhengquan Li,2 Dong Guo,1 Zhen Zhang,3 Jingming Yu,4 Guangdong Jiang,1 Xiaobo Xing,3 Shengjun Ji,5 Feng Jin3 1Weifang Medical University, Weifang, People’s Republic of China; 2Department of Laboratory Pathology, People’s Liberation Army 80th Group Military Hospital,...

Full description

Bibliographic Details
Main Authors:	Jia C, Li Z, Guo D, Zhang Z, Yu J, Jiang G, Xing X, Ji S, Jin F
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-12-01
Series:	OncoTargets and Therapy
Subjects:	brain metastases magnetic resonance spectroscopy stereotactic radiotherapy.
Online Access:	https://www.dovepress.com/brain-metastases-of-non-small-cell-lung-cancer-magnetic-resonance-spec-peer-reviewed-article-OTT

Similar Items

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2021-12-01)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
by: Jiang Xue-song, et al.
Published: (2012-03-01)

Treatment of Single or Multiple Brain Metastases by Hypofractionated Stereotactic Radiotherapy Using Helical Tomotherapy
by: Aiko Nagai, et al.
Published: (2014-04-01)

Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation
by: Laurence Mengue, et al.
Published: (2020-04-01)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
by: Carsten Herskind, et al.
Published: (2017-07-01)

Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy
by: Megumi Uto, et al.
Published: (2021-07-01)

Impact of PTV margin reduction (2 mm to 0 mm) on pseudoprogression in stereotactic radiotherapy of solitary brain metastases
by: Justine Badloe, et al.
Published: (2021-03-01)

Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
by: Dominik Oft, et al.
Published: (2021-01-01)

Efficiency of Stereotactic Conformal Radiotherapy in Lung Metastases with Active Breathing Control
by: Olga Yu. Anikeeva, PhD, et al.
Published: (2013-06-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases
by: Morgan Guénolé, et al.
Published: (2020-10-01)

Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial
by: Paul Lesueur, et al.
Published: (2020-02-01)

Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system
by: Niccolò Giaj-Levra, et al.
Published: (2019-10-01)

Hypofractionated conformal stereotactic radiotherapy in the treatment of AVMs and cerebral metastases
by: Lindvall, Peter
Published: (2006)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
by: Paul Lesueur, et al.
Published: (2018-07-01)

Radiotherapy management of brain metastases using conventional linear accelerator
by: Marcel Matzenauer, et al.
Published: (2016-09-01)

Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review
by: Guillaume Virbel, et al.
Published: (2021-07-01)

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
by: Matthew N. Mills, et al.
Published: (2021-05-01)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
by: Jaap D. Zindler, et al.
Published: (2017-07-01)

Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain Radiotherapy
by: Vincent Bourbonne, et al.
Published: (2021-03-01)

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
by: Carole Mercier, et al.
Published: (2019-09-01)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
by: Laila König, et al.
Published: (2020-02-01)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
by: Kang Liang Zeng, et al.
Published: (2019-05-01)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
by: Yining Gong, et al.
Published: (2019-10-01)

Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer
by: Loïg Vaugier, et al.
Published: (2021-01-01)

A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)
by: Carole Mercier, et al.
Published: (2018-08-01)

Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer
by: Chao Liu, et al.
Published: (2019-04-01)

Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors
by: Bellière, A., et al.
Published: (2022)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
by: Khush S. Aujla, et al.
Published: (2019-02-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases
by: Rami A. El Shafie, et al.
Published: (2020-05-01)

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases
by: Matthew N. Mills, et al.
Published: (2021-03-01)

Novel strategy in the treatment of liver metastases – Hepatic resection combined with stereotactic body radiotherapy
by: Peter Ihnát, et al.
Published: (2020-09-01)

Quality of Automated Stereotactic Radiosurgery Plans in Patients with 4 to 10 Brain Metastases
by: Anna Petoukhova, et al.
Published: (2021-07-01)

Stereotactic body radiotherapy using the CyberKnife® system in the treatment of patients with liver metastases: state of the art
by: Ihnát P, et al.
Published: (2018-08-01)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife<sup>®</sup> System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
by: Valentina Borzillo, et al.
Published: (2021-04-01)

Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis
by: Marco Lupattelli, et al.
Published: (2020-07-01)

Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
by: Fabian Weykamp, et al.
Published: (2021-06-01)

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

Cannot write session to /tmp/vufind_sessions/sess_unqoo3prftqpr4dm4saglgj0bd